The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study

References

• International Diabetes Federation. IDF Diabetes Atlas . 8th ed. Brussels (Belgium): International Diabetes Federation; 2017 Available from: http://www.diabetesatlas.org. Accessed 9 24, 2019.
   Google Scholar
• Shah AD , Langenberg C , Rapsomaniki E , et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol . 2015;3(2):105–113. doi:10.1016/S2213-8587(14)70219-0 25466521
   PubMed Web of Science ®Google Scholar
• Singh GM , Danaei G , Farzadfar F , et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One . 2013;8(7):e65174. doi:10.1371/journal.pone.0065174 23935815
   PubMed Web of Science ®Google Scholar
• Kanbay M , Jensen T , Solak Y , et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med . 2016;29:3–8. doi:10.1016/j.ejim.2015.11.026 26703429
   PubMed Web of Science ®Google Scholar
• Tuven B , Soysal P , Unutmaz G , Kaya D , Isik AT . Uric acid may be protective against cognitive impairment in older adults, but only in those without cardiovascular risk factors. Exp Gerontol . 2017;89:15–19. doi:10.1016/j.exger.2017.01.002 28062372
   PubMed Web of Science ®Google Scholar
• Muka T , de Jonge EAL , Kiefte de Jong JC , et al. The influence of serum uric acid on bone mineral density, hip geometry, and fracture risk: the rotterdam study. J Clin Endocrinol Metab . 2016;101(3):1113–1122. doi:10.1210/jc.2015-2446 26684274
   PubMed Web of Science ®Google Scholar
• Krishnan E , Akhras KS , Sharma H , et al. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM . 2013;106(8):721–729. doi:10.1093/qjmed/hct093 23620537
   PubMed Web of Science ®Google Scholar
• Bhole V , Choi JWJ , Kim SW , de Vera M , Choi H . Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med . 2010;123(10):957–961. doi:10.1016/j.amjmed.2010.03.027 20920699
   PubMed Web of Science ®Google Scholar
• Juraschek SP , McAdams-Demarco M , Miller ER , et al. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol . 2014;179(6):684–691. doi:10.1093/aje/kwt320 24418684
   PubMed Web of Science ®Google Scholar
• Liu J , Tao L , Zhao Z , et al. Two-year changes in hyperuricemia and risk of diabetes: a five-year prospective cohort study. J Diabetes Res . 2018;2018:1–7. doi:10.1155/2018/6905720
   Web of Science ®Google Scholar
• Serafinceanu C , Elian VI , Catrinoiu D , et al. Clinical and therapeutic characteristics of patients with type 2 diabetes mellitus in Romania - MENTOR study. Rom J Diabetes Nutr Metab Dis . 2018;25(4):409–418. doi:10.2478/rjdnmd-2018-0049
   Google Scholar
• Adiels M , Olofsson S-O , Taskinen M-R , Borén J . Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol . 2008;28(7):1225–1236. doi:10.1161/ATVBAHA.107.160192 18565848
   PubMed Web of Science ®Google Scholar
• de Oliveira EP , Burini RC . High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr . 2012;4(1):12. doi:10.1186/1758-5996-4-12 22475652
   PubMed Web of Science ®Google Scholar
• Thounaojam MC , Montemari A , Powell FL , et al. Monosodium urate contributes to retinal inflammation and progression of diabetic retinopathy. Diabetes . 2019;68(5):1014–1025. doi:10.2337/db18-0912 30728185
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 10. cardiovascular disease and risk management: standards of medical care in diabetes—2019. Diabetes Care . 2019;42(Supplement 1):S103–S123. doi:10.2337/dc19-S010 30559236
   PubMedGoogle Scholar
• O’Neill S , O’Driscoll L . Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev . 2015;16(1):1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Baidog A , Popa AR . Hyperuricemia - as a pathogenetic and independent risk factor in relation to the metabolic syndrome. Rom J Diabetes Nutr Metab Dis . 2018;25(3):335–341. doi:10.2478/rjdnmd-2018-0040
   Google Scholar
• Reilly MP , Rader DJ . The metabolic syndrome. Circulation . 2003;108(13):1546–1551. doi:10.1161/01.CIR.0000088846.10655.E0 14517150
   PubMed Web of Science ®Google Scholar
• Zhao J , Chen H , Liu N , et al. Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of Atherosclerosis. J Stroke Cerebrovasc Dis . 2017;26(12):2695–2699. doi:10.1016/j.jstrokecerebrovasdis.2016.10.012 28986198
   PubMed Web of Science ®Google Scholar
• Krishnan E , Svendsen K , Neaton JD , Grandits G , Kuller LH ; MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med . 2008;168(10):1104. doi:10.1001/archinte.168.10.1104 18504339
   PubMed Web of Science ®Google Scholar
• Cohen SD , Kimmel PL , Neff R , Agodoa L , Abbott KC . Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol . 2008;19(11):2204–2210. doi:10.1681/ASN.2007111256 18508965
   PubMed Web of Science ®Google Scholar
• Choi HK , Curhan G . Independent impact of gout on mortality and risk for coronary heart disease. Circulation . 2007;116(8):894–900. doi:10.1161/CIRCULATIONAHA.107.703389 17698728
   PubMed Web of Science ®Google Scholar
• Luk AJ , Levin GP , Moore EE , Zhou X-H , Kestenbaum BR , Choi HK . Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford) . 2009;48(7):804–806. doi:10.1093/rheumatology/kep069 19447769
   PubMed Web of Science ®Google Scholar
• Borghi C , Rosei EA , Bardin T , et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens . 2015;33(9):1729–1741. doi:10.1097/HJH.0000000000000701 26136207
   PubMed Web of Science ®Google Scholar
• Cibičková Ľ , Langová K , Vaverková H , Kubíčková V , Karásek D . Correlation of uric acid levels and parameters of metabolic syndrome. Physiol Res . 2017;66(3):481–487.28248530
   PubMed Web of Science ®Google Scholar
• De Cosmo S , Viazzi F , Pacilli A , et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol . 2015;10(11):1921–1929. doi:10.2215/CJN.03140315 26342044
   PubMed Web of Science ®Google Scholar
• Zhong C , Zhong X , Xu T , Xu T , Zhang Y . Sex-specific relationship between serum uric acid and risk of stroke: a dose-response meta-analysis of prospective studies. J Am Heart Assoc . 2017;6(4). doi:10.1161/JAHA.116.005042
   Web of Science ®Google Scholar
• Du L , Ma J , Zhang X . Higher serum uric acid may contribute to cerebral infarction in patients with type 2 diabetes mellitus: a meta-analysis. J Mol Neurosci . 2017;61(1):25–31. doi:10.1007/s12031-016-0848-y 27696108
   PubMed Web of Science ®Google Scholar
• Kawamoto R , Ninomiya D , Kasai Y , et al. Interaction between gender and uric acid on hemoglobin A1c in community-dwelling persons. J Endocrinol Invest . 2018;41(4):421–429. doi:10.1007/s40618-017-0760-5 28948573
   PubMed Web of Science ®Google Scholar
• Cui Y , Bu H , Ma X , Zhao S , Li X , Lu S . The relation between serum uric acid and HbA1c is dependent upon hyperinsulinemia in patients with newly diagnosed type 2 diabetes mellitus. J Diabetes Res . 2016;2016:7184123. doi:10.1155/2016/7184123 27403443
   PubMed Web of Science ®Google Scholar
• Wei F , Chang B , Yang X , Wang Y , Chen L , Li W-D . Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 diabetes. Sci Rep . 2016;6:28549. doi:10.1038/srep28549 27328642
   PubMed Web of Science ®Google Scholar
• Singh JA , Yu S . Allopurinol and the risk of stroke in older adults receiving medicare. BMC Neurol . 2016;16(1):164. doi:10.1186/s12883-016-0692-2 27604082
   PubMed Web of Science ®Google Scholar
• Weisman A , Tomlinson GA , Lipscombe LL , Perkins BA , Hawker GA . Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: a retrospective, population-based cohort study. Diabetes Obes Metab . 2019;21(6):1322–1329. doi:10.1111/dom.13656 30734980
   PubMed Web of Science ®Google Scholar
• Zhao Y , Xu L , Tian D , et al. Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: a meta-analysis of randomized controlled trials. Diabetes Obes Metab . 2018;20(2):458–462. doi:10.1111/dom.13101 28846182
   PubMed Web of Science ®Google Scholar